Search clinical trials for: NG-350A plus Pembrolizumab
Total 54 results
-
Akamis BioMerck Sharp & Dohme LLCRecruitingStudy of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (FORTIFY)Metastatic Cancer | Epithelial TumorUnited States, United Kingdom
-
Akamis BioCompletedMetastatic Cancer | Epithelial TumorUnited States
-
Valley Health SystemRecruitingMetastatic Solid Tumor | Cancer MetastaticUnited States
-
NGM Biopharmaceuticals, IncMerck Sharp & Dohme LLCRecruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Non-small Cell Lung Cancer | Colorectal Carcinoma | Bladder Urothelial Cancer | Endocervical...United States
-
Hospital of MacerataRecruiting
-
NGM Biopharmaceuticals, IncMerck Sharp & Dohme LLCRecruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Glioblastoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Endocervical CancerUnited States, Korea, Republic of, Taiwan
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingMelanoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Pancreas Cancer | Colo-rectal Cancer | Renal Cancer | HepatocarcinomaChina
-
Samsung Medical CenterRecruiting
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCUnknownSmall Cell Lung Cancer Extensive StageJapan
-
BioXcel Therapeutics IncActive, not recruitingProstate Cancer | Neuroendocrine Tumors | Small Cell CarcinomaUnited States, United Kingdom
-
Kineta Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | Sarcoma | Kidney Cancer | Carcinoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Solid Tumor | Prostate Cancer | Colo-rectal Cancer | Thyroid Cancer | Uterine CancerUnited States
-
Precigen, IncNational Cancer Institute (NCI)RecruitingCervical Cancer | HPV-Related Malignancy | HPV-Related CarcinomaUnited States
-
Akamis BioRecruitingSquamous Cell Carcinoma of the Head and NeckUnited Kingdom
-
Iovance Biotherapeutics, Inc.RecruitingMelanoma | Metastatic Melanoma | Unresectable MelanomaUnited States, Spain, Australia, France, Netherlands, Italy, Canada, Sweden
-
Rakuten Medical, Inc.Active, not recruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma | Metastatic Cutaneous Squamous Cell Carcinoma | Locally Advanced Cutaneous Squamous Cell CarcinomaUnited States
-
Peking Union Medical College HospitalCompletedCholangiocarcinoma | Biomarker | Combinational Immunotherapy | Liver Neoplasm Malignant PrimaryChina
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
Shanghai Zhongshan HospitalRecruitingEsophageal Squamous Cell Carcinoma | Neoadjuvant ChemoimmunotherapyChina
-
Institut für Klinische Krebsforschung IKF GmbH...Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel; MSD Sharp...RecruitingBiliary Tract Cancer | HER2 Gene MutationGermany
-
Tianjin Medical University Second HospitalRecruiting
-
University of CologneNot yet recruitingClassical Hodgkin LymphomaGermany
-
Highlight TherapeuticsMerck Sharp & Dohme LLCActive, not recruiting
-
National Taiwan University HospitalNot yet recruitingUnresectable Hepatocellular Carcinoma | Pembrolizumab | Stereotactic Body Radiotherapy | LenvatinibTaiwan
-
Australian and New Zealand Urogenital and Prostate...Merck Sharp & Dohme LLC; AmgenActive, not recruitingRenal Cell Carcinoma, Clear Cell | Metastatic Kidney CancerAustralia
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Triumvira Immunologics, Inc.Merck Sharp & Dohme LLCActive, not recruitingHER2 Positive Gastric Cancer | Metastatic HER2 Positive Gastroesophageal Junction CancerUnited States, Canada
-
Consorzio OncotechRecruitingOligometastatic Renal Cell CarcinomaItaly
-
Novartis PharmaceuticalsCompleted
-
The Methodist Hospital Research InstituteActive, not recruitingNon-Small Cell Lung Cancer | DNA Repair-Deficiency Disorders | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma Bladder | Classical Hodgkin Lymphoma | Malignant MelanomaUnited States
-
Changhai HospitalCompleted
-
Xiaorong DongNot yet recruitingSmall Cell Lung Cancer Extensive Stage
-
Yale UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingMelanoma | Non-small Cell Lung Cancer | Brain MetastasisUnited States
-
Fundacion para la Investigacion Biomedica del Hospital...Recruiting
-
Samsung Medical CenterUnknownNon-small Cell Lung Cancer MetastaticKorea, Republic of
-
Merck Sharp & Dohme LLCActive, not recruitingBladder CancerCanada, United States, Australia, Belgium, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Sweden, Thailand, Turkey, Ukraine, United Kingdom
-
xiaohua liNot yet recruitingGastroesophageal Junction Cancer
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
Imugene LimitedActive, not recruitingStomach Cancer | Gastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Cancer of Stomach | Stomach AdenocarcinomaTaiwan, Australia
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedNeoplasmsUnited States, Australia, Spain, Italy, Japan, Netherlands, Canada, France, China
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States, Australia
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruitingNon-squamous NSCLCChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage III Laryngeal Cancer AJCC v8 | Laryngeal Squamous Cell Carcinoma | Stage II Laryngeal Cancer AJCC v8United States
-
National Cancer Institute (NCI)RecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell CarcinomaUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
National Cancer Institute (NCI)RecruitingLung Non-Small Cell Carcinoma | Lung Non-Small Cell Squamous Carcinoma | Lung Non-Squamous Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8United States, Guam
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNeuroendocrine Neoplasm | Extensive Stage Small Cell Lung Carcinoma | Limited Stage Small Cell Lung CarcinomaUnited States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedUrothelial Carcinoma | Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Bladder Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral... and other conditionsUnited States